Crohn’s disease exclusion diet (CDED): An adjuvant therapy with biologics in management of pediatric Crohn’s disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202404560083036

Enrollment

Registered

2024-04-08

Start date

2024-05-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Nutritional, Metabolic, Endocrine Paediatrics

Interventions

dietry intervention

no intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with an active Crohn’s disease on biological treatment and conventional treatment. Age between 5-18 years.

Exclusion criteria

Exclusion criteria: Children with Crohn’s disease on steroid therapy course. Children less than 5 years old. Patient with any other causes of chronic diarrhea e.g ( congenital, metabolic causes…etc)

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of combined biological and conventional treatment (5-aminosalicylic acid, and azathioprine) versus combined biological and Crohn’s disease exclusion diet regarding disease course, remission, and it`s maintenance.	—

Secondary

Measure	Time frame
To assess the effect of CDED on the nutritional status of patients with an active Crohn’s disease.	—

Countries

Egypt

Contacts

Public ContactMarwa;Amera Ahmed Sedkey;Mohammed Hasnoon

Lecturer of pediatric;Lecturer of pediatric

marwasedkey@kasralainy.edu.eg;amerahasnoon0@gmail.com00201145712208;00201204000805

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026